COVID-19 Health System Response Monitor (HSRM)
The COVID-19 Health Systems Response Monitor (HSRM) contains information on how countries’ health systems responded to the pandemic between 2020 and early 2022. The Archive of individual country evidence is complemented by cross-country comparative Analyses which synthesise policy responses to key challenges presented by the crisis and point the way to building better-prepared and more resilient health systems.
Cross country analyses
How have countries used communication strategies to increase the uptake of COVID-19 vaccines? Lessons from the first rollout in Denmark and Israel
During the 2020 pandemic, scientists developed a vaccine against COVID-19 in a record time (Machingaidze & Wiysonge, 2021). By late 2020 and early 2021, countries around the world started rolling out COVID-19 vaccines to their populations.
What roles were played by public health agencies in Europe during the COVID-19 pandemic?
A widely-used definition of public health as ‘the science and art of preventing disease, prolonging life and promoting health through the organised efforts of society’ was put forward by Donald Acheson in 1988 (Acheson, 1988).
How did public health agencies and services communicate with specific groups during the COVID-19 pandemic?
The aim of this article is to explore some of the ways public health agencies and services communicated with specific groups during the COVID-19 pandemic.
What has been the role of national public health institutes in providing knowledge during the COVID-19 pandemic, including on the effects of public health and social measures?
This article covers two closely interrelated topics: the role of National Public Health Institutes (NPHIs) as knowledge providers during the COVID-19 pandemic and how to assess and evaluate the effects of public health and social measures (PHSM).
What was the role of public health agencies in gathering behavioural insights during the COVID-19 pandemic?
Individual-level behaviour drives the majority of risk factors that lead to disease. In fact, approximately 60% of the disease burden in Europe can be correlated with seven behaviour-induced risk factors.
How did public health agencies work to integrate health equity into public health practice during the COVID-19 pandemic?
It is widely acknowledged that the effects of the pandemic have not been experienced equally. As such, this health crisis has exposed and exacerbated pre-existing health inequalities in society.
How have public health agencies in the United Kingdom maintained routine vaccination during the COVID-19 pandemic?
Initial declines in routine vaccination uptake1 during the first few weeks of the COVID-19 pandemic led to timely action from public health and primary care in the United Kingdom (UK) and other countries in Europe.
What role did National Public Health Institutes in Europe play in monitoring the COVID-19 pandemic?
When the COVID-19 pandemic hit Europe in early 2020 (Spiteri et al., 2020), the National Public Health Institutes (NPHIs) took on the role of monitoring the spread of the Sars-CoV-2 virus and COVID-19.
What was the role of public health agencies in addressing the mental health needs of the population during the COVID-19 pandemic?
Public mental health is a relatively well-established sub-field of public health, and its role in the pandemic is well recognised (Campion et al., 2020).
How have governments and public health agencies responded to misinformation during the COVID-19 pandemic in Europe?
During the COVID-19 pandemic, Europe and the world witnessed a tremendous increase in misinformation. This includes false, inaccurate or incomplete information, which is shared without harmful intent, e.g., due to a lack of knowledge
How has the COVID-19 vaccination been rolled out in small countries within the European Region?
This snapshot examines the situation faced by small countries in the WHO European Region regarding their COVID-19 vaccination strategies in terms of supply, procurement, distribution, administration and vaccination uptake and coverage as well as related challenges.
What strategies are countries using to get COVID-19 vaccines to people in hard-to-reach groups?
Since the beginning of 2021, reports of the spread of genetic variants of the COVID-19 virus have increasingly shaped the evolution of the pandemic and countries’ response strategies across the WHO European Region.
Subscribe to our newsletter
Sign Up